611 related articles for article (PubMed ID: 15753008)
21. Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses.
Barnabas RV; Laukkanen P; Koskela P; Kontula O; Lehtinen M; Garnett GP
PLoS Med; 2006 May; 3(5):e138. PubMed ID: 16573364
[TBL] [Abstract][Full Text] [Related]
22. Acquisition of anal human papillomavirus (HPV) infection in women: the Hawaii HPV Cohort study.
Goodman MT; Shvetsov YB; McDuffie K; Wilkens LR; Zhu X; Ning L; Killeen J; Kamemoto L; Hernandez BY
J Infect Dis; 2008 Apr; 197(7):957-66. PubMed ID: 18429348
[TBL] [Abstract][Full Text] [Related]
23. High prevalence of high-risk oncogenic human papillomaviruses harboring atypical distribution in women of childbearing age living in Libreville, Gabon.
Si-Mohamed A; Ndjoyi-Mbiguino A; Cuschieri K; Onas IN; Colombet I; Ozouaki F; Goff JL; Cubie H; Bélec L
J Med Virol; 2005 Nov; 77(3):430-8. PubMed ID: 16173023
[TBL] [Abstract][Full Text] [Related]
24. The epidemiology of genital human papillomavirus infection.
Trottier H; Franco EL
Vaccine; 2006 Mar; 24 Suppl 1():S1-15. PubMed ID: 16406226
[TBL] [Abstract][Full Text] [Related]
25. Human papillomavirus infection in Ulaanbaatar, Mongolia: a population-based study.
Dondog B; Clifford GM; Vaccarella S; Waterboer T; Unurjargal D; Avirmed D; Enkhtuya S; Kommoss F; Wentzensen N; Snijders PJ; Meijer CJ; Franceschi S; Pawlita M
Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1731-8. PubMed ID: 18628425
[TBL] [Abstract][Full Text] [Related]
26. Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention.
Garland SM; Brotherton JM; Skinner SR; Pitts M; Saville M; Mola G; Jones RW
Vaccine; 2008 Aug; 26 Suppl 12():M80-8. PubMed ID: 18945417
[TBL] [Abstract][Full Text] [Related]
27. [Identification and typification of the human papilloma virus in women using the "Timely Detection of Cancer" program in Durango, Mexico].
Rodríguez-Reyes ER; Cerda-Flores RM; Solís Ríos NP; Quiñones Pérez JM; Cortés-Gutiérrez EI
Ginecol Obstet Mex; 2003 Sep; 71():471-5. PubMed ID: 14686060
[TBL] [Abstract][Full Text] [Related]
28. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
Arbyn M; Benoy I; Simoens C; Bogers J; Beutels P; Depuydt C
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):321-30. PubMed ID: 19124515
[TBL] [Abstract][Full Text] [Related]
29. The epidemiology behind the HPV vaccine discovery.
Koutsky L
Ann Epidemiol; 2009 Apr; 19(4):239-44. PubMed ID: 19344861
[TBL] [Abstract][Full Text] [Related]
30. Human papillomavirus infection among sexually active young women in the United States: Implications for developing a vaccination strategy.
Manhart LE; Holmes KK; Koutsky LA; Wood TR; Kenney DL; Feng Q; Kiviat NB
Sex Transm Dis; 2006 Aug; 33(8):502-8. PubMed ID: 16572039
[TBL] [Abstract][Full Text] [Related]
31. Human papillomavirus type-distribution in the cervix of Chinese women: a meta-analysis.
Bao YP; Li N; Smith JS; Qiao YL
Int J STD AIDS; 2008 Feb; 19(2):106-11. PubMed ID: 18334063
[TBL] [Abstract][Full Text] [Related]
32. Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica.
Herrero R; Castle PE; Schiffman M; Bratti MC; Hildesheim A; Morales J; Alfaro M; Sherman ME; Wacholder S; Chen S; Rodriguez AC; Burk RD
J Infect Dis; 2005 Jun; 191(11):1796-807. PubMed ID: 15871111
[TBL] [Abstract][Full Text] [Related]
33. Insulin-like growth factor axis and oncogenic human papillomavirus natural history.
Harris TG; Burk RD; Yu H; Minkoff H; Massad LS; Watts DH; Zhong Y; Gange S; Kaplan RC; Anastos K; Levine AM; Moxley M; Xue X; Fazzari M; Palefsky JM; Strickler HD
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):245-8. PubMed ID: 18199731
[TBL] [Abstract][Full Text] [Related]
34. Regulation of immune responses to HPV infection and during HPV-directed immunotherapy.
Bhat P; Mattarollo SR; Gosmann C; Frazer IH; Leggatt GR
Immunol Rev; 2011 Jan; 239(1):85-98. PubMed ID: 21198666
[TBL] [Abstract][Full Text] [Related]
35. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.
Castellsagué X; Díaz M; de Sanjosé S; Muñoz N; Herrero R; Franceschi S; Peeling RW; Ashley R; Smith JS; Snijders PJ; Meijer CJ; Bosch FX;
J Natl Cancer Inst; 2006 Mar; 98(5):303-15. PubMed ID: 16507827
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of human papillomavirus types in women screened by cytology in Germany.
Klug SJ; Hukelmann M; Hollwitz B; Düzenli N; Schopp B; Petry KU; Iftner T
J Med Virol; 2007 May; 79(5):616-25. PubMed ID: 17385693
[TBL] [Abstract][Full Text] [Related]
37. Differences in factors associated with oncogenic and nononcogenic human papillomavirus infection at the United States-Mexico border.
Giuliano AR; Papenfuss M; Abrahamsen M; Inserra P
Cancer Epidemiol Biomarkers Prev; 2002 Sep; 11(9):930-4. PubMed ID: 12223441
[TBL] [Abstract][Full Text] [Related]
38. International correlation between human papillomavirus prevalence and cervical cancer incidence.
Maucort-Boulch D; Franceschi S; Plummer M;
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):717-20. PubMed ID: 18349293
[TBL] [Abstract][Full Text] [Related]
39. [Vaccination against human papillomavirus for the prevention of cervical cancer].
Quint WG; ter Harmsel WA; van Doorn LJ
Ned Tijdschr Geneeskd; 2006 Jun; 150(25):1380-4. PubMed ID: 16841585
[TBL] [Abstract][Full Text] [Related]
40. Cervical coinfection with human papillomavirus (HPV) types and possible implications for the prevention of cervical cancer by HPV vaccines.
Mendez F; Munoz N; Posso H; Molano M; Moreno V; van den Brule AJ; Ronderos M; Meijer C; Munoz A;
J Infect Dis; 2005 Oct; 192(7):1158-65. PubMed ID: 16136457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
